LENZ Therapeutics (LENZ) Interest & Investment Income (2023 - 2026)
LENZ Therapeutics' Interest & Investment Income came in at $1.99 million for Q3 2026, down 9.8% from $2.2 million a year earlier and down 12.6% from the prior quarter.
Powered by 
Analysis
LENZ Therapeutics (LENZ) Interest & Investment Income (2023 - 2026) Analysis & Trends
Over the trailing twelve months to Sep 30, 2026, LENZ Therapeutics reported Interest & Investment Income of $9.89 million, up 5.9% year-over-year; for FY2025, it came in at $9.76 million, up 14.1% from FY2024.
- Going back by year, Interest & Investment Income was $8.55 million in FY2024 (+290.7%) and $2.19 million in FY2023.
- The Q3 2026 figure represents the lowest quarterly Interest & Investment Income since Q1 2024.
- Year-over-year, Interest & Investment Income increased in five of the last eight quarters, with growth averaging 48.7%.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q2 2024 (growth of 881.3%), and the weakest in Q3 2025 (a decline of 19.6%).
- Business Quant data shows LENZ's Interest & Investment Income at $2.27 million (Q2 2026), $2.64 million (Q1 2026) and $2.99 million (Q4 2025) in the three quarters before Q3 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 186.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 67.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | LENZ Therapeutics | 128.82 Mn | -839.21 Mn | 2.93 Mn | 1.99 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.99 Mn |
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 2.64 Mn |
| Dec 31, 2025 | 2.99 Mn |
| Sep 30, 2025 | 2.20 Mn |
| Jun 30, 2025 | 2.25 Mn |
| Mar 31, 2025 | 2.32 Mn |
| Dec 31, 2024 | 2.57 Mn |
| Sep 30, 2024 | 2.74 Mn |
| Jun 30, 2024 | 2.46 Mn |
| Mar 31, 2024 | 788,000.00 |
| Dec 31, 2023 | 851,000.00 |
| Sep 30, 2023 | 1.09 Mn |
| Jun 30, 2023 | 251,000.00 |
API Access
LENZ Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LENZ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "LENZ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=LENZ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();